Recro Pharma, Inc

(NASDAQ:REPH)

Latest On Recro Pharma, Inc (REPH):

Date/Time Type Description Signal Details
2022-03-02 05:43 ESTNewsRecro Pharma GAAP EPS of -$0.04 beats by $0.03, revenue of $22.3M beats by $0.89MN/A
2022-03-02 05:43 ESTNewsRecro Pharma GAAP EPS of $0.04 beats by $0.11, revenue of $22.3M beats by $0.89MN/A
2022-03-02 05:43 ESTNewsRecro Pharma, Inc. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-03-02 05:43 ESTNewsRecro Pharma, Inc. (REPH) CEO David Enloe On Q4 2021 Results - Earnings Call TranscriptN/A
2022-02-28 17:39 ESTNewsRecro Pharma Q4 2021 Earnings PreviewN/A
2022-01-26 10:02 ESTNewsRecro Pharma gets $1.5M U.S. contract to develop topical therapy to prevent skin cancerN/A
2021-11-18 00:14 ESTNewsWarning: REPH is at high risk of performing badlyN/A
2021-11-10 14:42 ESTNewsRecro Pharma EPS in-line, beats on revenueN/A
2021-11-10 14:39 ESTNewsRecro Pharma, Inc. (REPH) CEO David Enloe on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 17:39 ESTNewsRecro Pharma Q3 2021 Earnings PreviewN/A
2021-10-20 14:23 ESTNewsRecro Pharma awarded new NIH development and manufacturing contractN/A
2021-08-13 19:41 ESTNewsRecro acquires San Diego-based IRISYS for $49.85MN/A
2021-08-10 10:33 ESTNewsRecro Pharma EPS beats by $0.12, beats on revenueN/A
2021-08-10 10:32 ESTNewsRecro Pharma, Inc. (REPH) CEO David Enloe on Q2 2021 Results - Earnings Call TranscriptN/A
2021-08-10 10:31 ESTNewsRecro Pharma to acquire full service CDMO for ~$50MN/A
2021-05-07 14:20 ESTNewsRecro Pharma jumps 15% on Q1 result estimates beatN/A
2021-05-06 18:00 ESTNewsRecro Pharma EPS beats by $0.03, beats on revenueN/A
2021-03-01 12:15 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the 2022 year.Buy
2021-03-01 12:15 ESTEarnings EstimateAn EPS average of -$0.12 is estimated for the quarter ending on June 30, 2021.Buy
2021-02-28 17:57 ESTFinancialsCompany financials have been released.Neutral
2021-02-28 10:27 ESTNewsRecro Pharma, Inc. (REPH) CEO David Enloe on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-27 00:44 ESTNewsRecro Pharma EPS misses by $0.22, misses on revenueN/A
2021-02-27 00:43 ESTNewsRecro Pharma, Inc. 2020 Q4 - Results - Earnings Call PresentationN/A
2021-02-23 19:54 ESTNewsRecro amends Athyrium credit facility, de-levers debtN/A
2021-02-15 21:44 ESTNewsRevisiting Recro PharmaN/A
2021-01-05 12:37 ESTAnalyst RatingThe Analyst Target Price has increased from $5 to $5.5.Buy
2021-01-01 08:36 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $5.Neutral
2020-12-17 13:09 ESTAnalyst RatingThe Analyst Target Price has increased from $6.75 to $7.5.Buy
2020-11-26 21:21 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 05:04 ESTFinancialsCompany financials have been released.Neutral
2020-11-11 12:50 ESTAnalyst RatingThe Analyst Target Price has decreased from $7.5 to $6.75.Neutral
2020-11-10 23:14 ESTNewsRecro Pharma, Inc. (REPH) CEO Geraldine Henwood on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-10 13:01 ESTEarnings EstimateAn EPS average of -$0.20 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-09 17:53 ESTNewsRecro Pharma EPS beats by $0.11, beats on revenueN/A
2020-11-09 17:50 ESTNewsRecro Pharma stock +21% on Q3 earnings smasherN/A
2020-11-08 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 16:58 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 13:53 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 06:01 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:57 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 09:57 ESTAnalyst RatingThe Analyst Target Price has decreased from $8.5 to $7.5.Neutral
2020-08-12 13:41 ESTFinancialsCompany financials have been released.Neutral
2020-08-11 21:45 ESTAnalyst RatingThe Analyst Target Price has decreased from $9.5 to $8.5.Neutral
2020-08-10 20:35 ESTNewsRecro Pharma EPS misses by $0.09, misses on revenueN/A
2020-08-10 20:34 ESTNewsQ2 miss pressures Recro Pharma, down 26%N/A
2020-08-10 20:33 ESTNewsRecro Pharma (REPH) Investor Presentation - SlideshowN/A
2020-08-10 20:33 ESTNewsRecro Pharma, Inc. (REPH) CEO Gerri Henwood on Q2 2020 Results - Earnings Call TranscriptN/A
2020-08-06 13:44 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 09:33 ESTAnalyst RatingThe Analyst Target Price has decreased from $10.5 to $9.5.Neutral
2020-07-30 17:39 ESTFinancialsCompany financials have been released.Neutral

About Recro Pharma, Inc (REPH):

Recro Pharma, Inc., a contract development and manufacturing organization, engages in the development, manufacturing, and packaging of oral solid dose drug products in the United States and internationally. The company was formerly known as Recro Pharma I, Inc. and changed its name to Recro Pharma, Inc. in August 2008. Recro Pharma, Inc. was incorporated in 2007 and is based in Malvern, Pennsylvania.

REPH Quotes by TradingView

See Advanced Chart

General

  • Name Recro Pharma, Inc
  • Symbol REPH
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryDrug Manufacturers-Specialty & Generic
  • Full Time Employees 185
  • Last Split Factor1115:1000
  • Last Split Date2019-11-22
  • Fiscal Year EndDecember
  • IPO Date2014-03-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryPharmaceuticals
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.recrogainesville.com
View More

Valuation

  • Trailing PE 35.15
  • Forward PE 18.25
  • Price/Sales (Trailing 12 Mt.) 1.35
  • Enterprise Value Revenue 3.17
  • Enterprise Value EBITDA 1029.41
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.58
  • Next Year EPS Estimate -$0.18
  • Next Quarter EPS Estimate -$0.18
  • Profit Margin -41%
  • Operating Margin -13%
  • Return on Assets -5%
  • Revenue 66.5 million
  • Earnings Per Share -$2.75
  • Revenue Per Share $2.8
  • Gross Profit 12.37 million
  • Quarterly Earnings Growth -43.8%
View More

Highlights

  • Market Capitalization 121.23 million
  • EBITDA 205000
  • Analyst Target Price $5.5
  • Book Value Per Share -$0.84
View More

Share Statistics

  • Shares Outstanding 33.21 million
  • Shares Float 28.34 million
  • % Held by Insiders 240%
  • % Held by Institutions 79.63%
  • Shares Short 1.26 million
  • Shares Short Prior Month 1.34 million
  • Short Ratio 1.63
  • Short % of Float 4%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 1.16
  • 52 Week High $9.19
  • 52 Week Low $1.49
  • 50 Day Moving Average 3.91
  • 200 Day Moving Average 2.78
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Recro Pharma, Inc (REPH) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Recro Pharma, Inc (REPH) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-26$9.91 million-$0.48-$0.26-88.24%
2020-09-302020-11-09$N/A-$0.09-$0.2156.1%
2020-06-302020-08-10$N/A-$0.25-$0.16-56.25%
2020-03-312020-05-11$21.78 million-$0.33-$0.03-890.99%
2019-12-312020-03-04$N/A-$0.42-$0.23-82.61%
2019-09-302019-11-08$25.26 million-$0.19-$0.16-21.79%
2019-06-302019-08-08$31.26 million-$0.13-$0.4269.05%
2019-03-312019-05-10$25.07 million-$0.09-$1.0391.23%
2018-12-312019-02-19$17.78 million-$1.92-$0.75-157.37%
2018-09-302018-11-07$18.28 million-$0.64-$0.708.05%
2018-06-302018-08-07$21.74 million-$0.62-$1.4557.24%
2018-03-312018-05-09$19.54 million-$0.65-$0.7614.1%
2017-12-312018-02-27$19.04 million-$1.27-$1.03-23.3%
2017-09-302017-11-09$17.11 million-$0.48-$0.7536.28%
2017-06-302017-08-10$16.93 million-$0.46-$0.5719.3%
2017-03-312017-05-11$18.74 million-$0.42-$0.5928.41%
2016-12-312017-03-06$17.36 million-$0.81-$0.9917.77%
2016-09-302016-11-10$16.95 million-$0.50-$0.7835.69%
2016-06-302016-08-11$17.28 million-$0.83-$0.78-6.41%
2016-03-312016-05-12$17.74 million-$0.71-$0.66-7.58%
2015-12-312016-03-24$16.75 million$1.13-$0.43362.79%
2015-09-302015-11-13$16.54 million-$0.24-$0.20-20%
2015-06-302015-08-14$18.66 million-$0.17-$0.03-466.67%
2015-03-312015-05-12$N/A-$0.53-$0.577.02%
2014-12-312015-03-25$N/A-$0.45-$0.6833.82%
2014-09-302014-11-10$N/A-$0.61-$0.51-19.61%
2014-06-302014-08-12$N/A-$0.36-$0.25-44%
2014-03-312014-05-12$N/A-$0.20-$0.3644.44%

Recro Pharma, Inc (REPH) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Recro Pharma, Inc (REPH) Chart:

Recro Pharma, Inc (REPH) News:

Below you will find a list of latest news for Recro Pharma, Inc (REPH) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Recro Pharma, Inc (REPH) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest REPH Trades:

Date Shares Price
Mar 21, 2022 7:56 PM EST10$2.13
Mar 21, 2022 7:59 PM EST100$2.08
Mar 21, 2022 7:59 PM EST100$2.08
Mar 21, 2022 7:59 PM EST56$2.08
Mar 21, 2022 7:59 PM EST100$2.05

Recro Pharma, Inc (REPH) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000455/0001192482-20-000455-index.htm
2019-03-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1588972/000000000019003796/0000000000-19-003796-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000021545719006825/0000215457-19-006825-index.htm
2019-06-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000021545719008029/0000215457-19-008029-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000083423720008208/0000834237-20-008208-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000090571819000210/0000905718-19-000210-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000090571820000209/0000905718-20-000209-index.htm
2018-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2018-05-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000091957418003942/0000919574-18-003942-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000091957420001115/0000919574-20-001115-index.htm
2018-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248218000277/0001192482-18-000277-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000011/0001192482-19-000011-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000013/0001192482-19-000013-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000017/0001192482-19-000017-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000018/0001192482-19-000018-index.htm
2019-01-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000020/0001192482-19-000020-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000033/0001192482-19-000033-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000034/0001192482-19-000034-index.htm
2019-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000035/0001192482-19-000035-index.htm
2019-02-145Annual statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000084/0001192482-19-000084-index.htm
2019-02-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000090/0001192482-19-000090-index.htm
2019-02-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000091/0001192482-19-000091-index.htm
2019-02-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000092/0001192482-19-000092-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000169/0001192482-19-000169-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000170/0001192482-19-000170-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000242/0001192482-19-000242-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000243/0001192482-19-000243-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000244/0001192482-19-000244-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000245/0001192482-19-000245-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000247/0001192482-19-000247-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000248/0001192482-19-000248-index.htm
2019-05-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000249/0001192482-19-000249-index.htm
2019-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000254/0001192482-19-000254-index.htm
2019-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000256/0001192482-19-000256-index.htm
2019-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000271/0001192482-19-000271-index.htm
2019-06-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000277/0001192482-19-000277-index.htm
2019-11-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000404/0001192482-19-000404-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000443/0001192482-19-000443-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000486/0001192482-19-000486-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000488/0001192482-19-000488-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000490/0001192482-19-000490-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000492/0001192482-19-000492-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000495/0001192482-19-000495-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000497/0001192482-19-000497-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000499/0001192482-19-000499-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000502/0001192482-19-000502-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000504/0001192482-19-000504-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248219000545/0001192482-19-000545-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000003/0001192482-20-000003-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000004/0001192482-20-000004-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000051/0001192482-20-000051-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000052/0001192482-20-000052-index.htm
2020-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000128/0001192482-20-000128-index.htm
2020-04-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000289/0001192482-20-000289-index.htm
2020-04-204/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000291/0001192482-20-000291-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000336/0001192482-20-000336-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000337/0001192482-20-000337-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000338/0001192482-20-000338-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000339/0001192482-20-000339-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000340/0001192482-20-000340-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000341/0001192482-20-000341-index.htm
2020-06-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1588972/000119248220000455/0001192482-20-000455-index.htm
2018-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518240338/0001193125-18-240338-index.htm
2018-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518265422/0001193125-18-265422-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518266683/0001193125-18-266683-index.htm
2018-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518274664/0001193125-18-274664-index.htm
2018-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518288535/0001193125-18-288535-index.htm
2018-10-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518295218/0001193125-18-295218-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518320106/0001193125-18-320106-index.htm
2018-12-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518345995/0001193125-18-345995-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312518360760/0001193125-18-360760-index.htm
2019-01-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519002554/0001193125-19-002554-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519003069/0001193125-19-003069-index.htm
2019-02-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519041057/0001193125-19-041057-index.htm
2019-02-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519043457/0001193125-19-043457-index.htm
2019-02-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1588972/000119312519043569/0001193125-19-043569-index.htm
2019-02-19S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1588972/000119312519043708/0001193125-19-043708-index.htm
2019-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1588972/000119312519044213/0001193125-19-044213-index.htm
2019-02-19S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1588972/000119312519044221/0001193125-19-044221-index.htm
2019-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519061623/0001193125-19-061623-index.htm
2019-03-068-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519065713/0001193125-19-065713-index.htm
2019-03-07S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1588972/000119312519065767/0001193125-19-065767-index.htm
2019-03-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1588972/000119312519065773/0001193125-19-065773-index.htm
2019-03-20CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1588972/000119312519080940/0001193125-19-080940-index.htm
2019-03-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1588972/000119312519081143/0001193125-19-081143-index.htm
2019-03-21DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1588972/000119312519081146/0001193125-19-081146-index.htm
2019-03-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519083535/0001193125-19-083535-index.htm
2019-03-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519089165/0001193125-19-089165-index.htm
2019-03-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1588972/000119312519090004/0001193125-19-090004-index.htm
2019-04-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519099170/0001193125-19-099170-index.htm
2019-04-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519109786/0001193125-19-109786-index.htm
2019-05-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519143600/0001193125-19-143600-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519148046/0001193125-19-148046-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519151108/0001193125-19-151108-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519216074/0001193125-19-216074-index.htm
2019-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519276363/0001193125-19-276363-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519279889/0001193125-19-279889-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519284014/0001193125-19-284014-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519287810/0001193125-19-287810-index.htm
2019-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519290504/0001193125-19-290504-index.htm
2019-11-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519301244/0001193125-19-301244-index.htm
2019-12-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519308407/0001193125-19-308407-index.htm
2019-12-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312519321012/0001193125-19-321012-index.htm
2020-01-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520005473/0001193125-20-005473-index.htm
2020-03-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520060869/0001193125-20-060869-index.htm
2020-03-04S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1588972/000119312520060901/0001193125-20-060901-index.htm
2020-03-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520068813/0001193125-20-068813-index.htm
2020-05-01DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1588972/000119312520131095/0001193125-20-131095-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520138266/0001193125-20-138266-index.htm
2020-05-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520140620/0001193125-20-140620-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520144139/0001193125-20-144139-index.htm
2020-07-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520202697/0001193125-20-202697-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520214072/0001193125-20-214072-index.htm
2020-08-10424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1588972/000119312520214135/0001193125-20-214135-index.htm
2020-09-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1588972/000119312520250613/0001193125-20-250613-index.htm
2019-02-12SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000119380519000189/0001193805-19-000189-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1588972/000145307219000041/0001453072-19-000041-index.htm
2018-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459018019638/0001564590-18-019638-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459018027700/0001564590-18-027700-index.htm
2019-02-1910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1588972/000156459019003187/0001564590-19-003187-index.htm
2019-05-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459019018460/0001564590-19-018460-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459019030405/0001564590-19-030405-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459019042010/0001564590-19-042010-index.htm
2020-03-0410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1588972/000156459020008538/0001564590-20-008538-index.htm
2020-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1588972/000156459020013681/0001564590-20-013681-index.htm
2020-03-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1588972/000156459020013688/0001564590-20-013688-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459020023842/0001564590-20-023842-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1588972/000156459020038590/0001564590-20-038590-index.htm
2019-03-21EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1588972/999999999519000490/9999999995-19-000490-index.htm
2019-03-07CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1588972/999999999719000813/9999999997-19-000813-index.htm
2019-03-18CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1588972/999999999719001378/9999999997-19-001378-index.htm

Recro Pharma, Inc (REPH) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Recro Pharma, Inc (REPH). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 240%
Institutional Ownership: 7963%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-05-17Arnaud AjdlerDirectorBuy40,000.009.00360,000.001,104,546.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000271/0001192482-19-000271-index.htm
2018-06-05Ryan David LakeChief Financial OfficerBuy2,500.0014,000.00https://www.sec.gov/Archives/edgar/data/1588972/000119248218000277/0001192482-18-000277-index.htm
2019-12-05Arnaud AjdlerDirectorBuy7,439.0015,394.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000486/0001192482-19-000486-index.htm
2020-04-17GERALDINE HENWOODPresident and CEOSell80,000.008.22657,600.00161,194.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000289/0001192482-20-000289-index.htm
2019-05-13GERALDINE HENWOODPresident and CEOSell21,306.008.89189,380.51198,141.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000256/0001192482-19-000256-index.htm
2018-05-24Healthcare Master Fund Ltd Broadfin10% Share HolderSell25,000.005.51137,750.002,048,025.00https://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2018-05-24Healthcare Master Fund Ltd Broadfin10% Share HolderSell50,000.005.65282,500.002,073,025.00https://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2019-01-18GERALDINE HENWOODPresident and CEOBuy35,801.00210,809.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000035/0001192482-19-000035-index.htm
2018-05-24Healthcare Master Fund Ltd Broadfin10% Share HolderSell45,700.006.00274,200.002,123,025.00https://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2019-01-18GERALDINE HENWOODPresident and CEOBuy5,000.00215,809.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000035/0001192482-19-000035-index.htm
2018-05-24Healthcare Master Fund Ltd Broadfin10% Share HolderSell38,000.005.99227,620.002,168,725.00https://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2019-05-13GERALDINE HENWOODPresident and CEOSell123,500.008.891,097,915.00219,447.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000256/0001192482-19-000256-index.htm
2018-05-24Healthcare Master Fund Ltd Broadfin10% Share HolderSell29,300.005.84171,112.002,206,725.00https://www.sec.gov/Archives/edgar/data/1588972/000091957418003940/0000919574-18-003940-index.htm
2019-05-09Bryan M. ReasonsDirectorBuy7,955.0022,987.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000244/0001192482-19-000244-index.htm
2020-05-07Arnaud AjdlerDirectorBuy8,363.0023,757.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000341/0001192482-20-000341-index.htm
2019-01-18Ryan David LakeChief Financial OfficerBuy11,264.0024,285.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000033/0001192482-19-000033-index.htm
2019-12-05GERALDINE HENWOODPresident and CEOBuy93,550.00246,691.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000488/0001192482-19-000488-index.htm
2020-01-18GERALDINE HENWOODPresident and CEOBuy5,000.00246,746.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000051/0001192482-20-000051-index.htm
2019-05-09Michael BerelowitzDirectorBuy7,955.0027,412.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000243/0001192482-19-000243-index.htm
2019-05-09William AshtonDirectorBuy7,955.0027,412.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000248/0001192482-19-000248-index.htm
2019-05-09WINSTON J CHURCHILLDirectorBuy7,955.0027,412.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000247/0001192482-19-000247-index.htm
2019-05-09Karen FlynnDirectorBuy7,955.0028,212.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000254/0001192482-19-000254-index.htm
2019-05-09ALFRED ALTOMARIDirectorBuy7,955.0028,912.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000249/0001192482-19-000249-index.htm
2019-01-20Ryan David LakeChief Financial OfficerBuy5,750.0030,035.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000033/0001192482-19-000033-index.htm
2019-12-05Bryan M. ReasonsDirectorBuy9,156.0032,143.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000492/0001192482-19-000492-index.htm
2019-06-05Ryan David LakeChief Financial OfficerBuy2,500.0032,248.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000277/0001192482-19-000277-index.htm
2019-05-13GERALDINE HENWOODPresident and CEOBuy123,500.002.47305,045.00342,947.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000256/0001192482-19-000256-index.htm
2019-05-09Wayne WeismanDirectorBuy7,955.0034,412.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000245/0001192482-19-000245-index.htm
2019-12-05Karen FlynnDirectorBuy11,071.0039,283.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000545/0001192482-19-000545-index.htm
2019-01-18Michael CelanoChief Operating OfficerBuy12,672.0039,445.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000034/0001192482-19-000034-index.htm
2020-05-07Bryan M. ReasonsDirectorBuy8,363.0040,506.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000339/0001192482-20-000339-index.htm
2019-12-05Michael BerelowitzDirectorBuy13,848.0041,260.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000502/0001192482-19-000502-index.htm
2019-12-05WINSTON J CHURCHILLDirectorBuy15,284.0042,696.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000495/0001192482-19-000495-index.htm
2019-12-05ALFRED ALTOMARIDirectorBuy15,284.0044,196.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000497/0001192482-19-000497-index.htm
2019-12-05William AshtonDirectorBuy17,582.0044,994.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000499/0001192482-19-000499-index.htm
2019-01-18Michael CelanoChief Operating OfficerBuy6,400.0045,845.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000034/0001192482-19-000034-index.htm
2019-12-05Ryan David LakeChief Financial OfficerBuy17,283.0048,812.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000504/0001192482-19-000504-index.htm
2020-05-07Michael BerelowitzDirectorBuy8,363.0049,623.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000337/0001192482-20-000337-index.htm
2019-12-05Wayne WeismanDirectorBuy15,284.0049,696.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000490/0001192482-19-000490-index.htm
2020-05-07WINSTON J CHURCHILLDirectorBuy8,363.0051,059.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000336/0001192482-20-000336-index.htm
2020-05-07William AshtonDirectorBuy8,363.0053,357.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000338/0001192482-20-000338-index.htm
2020-05-07Wayne WeismanDirectorBuy8,363.0058,059.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000340/0001192482-20-000340-index.htm
2020-02-03Ryan David LakeChief Financial OfficerBuy12,000.0058,738.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000128/0001192482-20-000128-index.htm
2020-06-05Ryan David LakeChief Financial OfficerBuy2,500.0061,238.00https://www.sec.gov/Archives/edgar/data/1588972/000119248220000455/0001192482-20-000455-index.htm
2019-05-09Arnaud AjdlerDirectorBuy7,955.007,955.00https://www.sec.gov/Archives/edgar/data/1588972/000119248219000242/0001192482-19-000242-index.htm